| Developability assessment of physicochemical properties and stability profiles of HIV-1 BG505 SOSIP. 664 and BG505 SOSIP. v4. 1-GT1. 1 gp140 envelope glycoprotein trimers as … N Whitaker, JM Hickey, K Kaur, J Xiong, N Sawant, A Cupo, WH Lee, ... Journal of pharmaceutical sciences 108 (7), 2264-2277, 2019 | 25 | 2019 |
| Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV … N Sawant, K Kaur, DA Holland, JM Hickey, S Agarwal, JR Brady, ... Journal of pharmaceutical sciences 110 (3), 1042-1053, 2021 | 14 | 2021 |
| Mechanism of thimerosal-induced structural destabilization of a recombinant rotavirus P [4] protein antigen formulated as a multi-dose vaccine K Kaur, J Xiong, N Sawant, S Agarwal, JM Hickey, DA Holland, ... Journal of pharmaceutical sciences 110 (3), 1054-1066, 2021 | 10 | 2021 |
| Interaction of aluminum-adjuvanted recombinant P [4] protein antigen with preservatives: Storage stability and backbone flexibility studies N Sawant, SB Joshi, DD Weis, DB Volkin Journal of Pharmaceutical Sciences 111 (4), 970-981, 2022 | 7 | 2022 |
| Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency D McAdams, M Estrada, D Holland, J Singh, N Sawant, JM Hickey, ... Vaccine 40 (34), 5069-5078, 2022 | 6 | 2022 |
| Crystallization of a nonreplicating rotavirus vaccine candidate MS Hong, K Kaur, N Sawant, SB Joshi, DB Volkin, RD Braatz Biotechnology and Bioengineering 118 (4), 1750-1756, 2021 | 4 | 2021 |
| Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV … N Sawant JOURNAL OF PHARMACEUTICAL SCIENCES 110 (4), 1867-1867, 2021 | | 2021 |
| Developability Assessments and Analytical Characterization of Recombinant Protein Antigens Formulated as Low-Cost, Multi-Dose, Aluminum-Adjuvanted Vaccines N Sawant University of Kansas, 2021 | | 2021 |
| Application of analytical characterization tools in process and formulation development of low cost vaccines using the ULTRA manufacturing platform K Kaur, JM Hickey, N Sawant, DA Holland, SB Joshi, DB Volkin | | 2018 |
